Developer docs
API playgroundTry for free, no card

Search company profiles

SeaSpine

Full company profile

uuid0004kmd

Namestring
SeaSpine
Legal namestring
SeaSpine Orthopedics Corporation
Websiteurl
seaspine.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

SeaSpine Orthopedics Corporation is a Carlsbad, California-based medical technology company that designs, develops, and commercializes spinal implants and orthobiologics for use by healthcare professionals in spinal and cranial surgical procedures. The company's product portfolio is organized around two primary categories — Spinal Implants (hardware for spinal stabilization, fusion, and correction) and Orthobiologics (biologic products supporting bone healing and regeneration) — supplemented by surgical navigation technology acquired through the 2021 purchase of Toronto-based 7D Surgical. The 7D Surgical platform uses optical technologies and machine vision to enable image-guided surgical navigation, extending SeaSpine's clinical reach from implants into computer-vision-assisted procedures.

SeaSpine sells prescription-use medical devices through a direct enterprise field sales model targeting hospitals, surgical centers, and spine surgeons in the United States. Products are FDA-regulated prescription devices, with the company maintaining entries in the FDA's Global Unique Device Identification Database (GUDID) and providing electronic Instructions for Use (eIFU) to clinicians. Pricing is not publicly disclosed, consistent with enterprise medical device contracting.

In 2022, SeaSpine was acquired by Orthofix Medical Inc. (NASDAQ: ORFI) and now operates as part of Orthofix's spine solutions division. The combined Orthofix entity reported full-year 2025 net sales of $822.3 million, up 2.9% year-over-year. SeaSpine's products continue to be distributed under both the SeaSpine and 7D Surgical brand labels through the Orthofix commercial infrastructure, with the seaspine.com website now redirecting customers to Orthofix.com for the expanded portfolio.

Short descriptiontext

SeaSpine Orthopedics Corporation develops and commercializes spinal implants, orthobiologics, and machine-vision surgical navigation systems for hospitals, surgical centers, and spine surgeons. Acquired by Orthofix Medical Inc. in 2022, it now operates within Orthofix's spine solutions division.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal implants, orthobiologics products, surgical navigation systems, spinal fusion devices, cranial surgery technology
Industry3 codes
1Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
CodeHLAHAEACPrimaryYes
2Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
CodeHLAHAEAGPrimaryNo
3Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Spinal Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Spinal Implants
TypeHardware Sales
Description

Sale of spinal implant products including surgical hardware for spinal procedures

2Orthobiologics
TypeHardware Sales
Description

Biologic products used in spinal and surgical applications including cancellous sponge medical products

Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
17D Surgical
Description

Optical technologies and machine vision system for surgical navigation acquired by SeaSpine in 2021

biospace.com
Core offering1 text field

SeaSpine manufactures and sells prescription-use spinal implants and orthobiologics for spinal surgical procedures, including biologic products that support bone healing and surgical hardware for stabilization, fusion, and correction of spinal disorders. Following its 2021 acquisition of 7D Surgical, the company also offers optical and machine vision-based surgical navigation technology for spinal and cranial surgeries. Products are intended for use by healthcare professionals in hospital and surgical center settings.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SeaSpine Orthopedics Corporation offers a portfolio of medical devices and products for spinal surgery, consisting of two main product categories: Orthobiologics (biologic products supporting bone healing and regeneration) and Spinal Implants (surgical devices for spinal stabilization and fusion). The company expanded its technological capabilities through the 2021 acquisition of 7D Surgical, adding optical and machine vision-based surgical navigation technology for spinal and cranial procedures. SeaSpine is now part of Orthofix, with its products integrated under the Orthofix brand portfolio.

Product and service3 records
1Orthobiologics
CategoryOrthobiologics / Surgical Biologics
Description

Biologic products used in orthopedic and spinal surgical procedures, designed to support bone healing and regeneration for healthcare professionals in hospital and surgical center settings.

2Spinal Implants
CategorySpinal Implants / Surgical Hardware
Description

Surgical implants and devices used in spinal surgical procedures for stabilization, fusion, and correction of spinal disorders; intended for use by healthcare professionals.

37D Surgical Navigation
CategorySurgical Navigation Technology
Description

Optical technologies and machine vision-based surgical navigation systems for spinal and cranial surgeries, acquired by SeaSpine in 2021 to expand its technological capabilities for healthcare professionals.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spine-focused medtech specializing in minimally invasive and lateral spine surgery; competes with SeaSpine in spinal implants and procedural technologies.

TypeBroad incumbent
Description

Broad orthopedics and spine franchise within J&J; competes with SeaSpine across spinal implants, biologics, and surgical enabling technologies.

TypeBroad incumbent
Description

Operates a sizable Spine division alongside broader orthopedics; competes with SeaSpine in spinal implants and surgical navigation through its acquired enabling-technology assets.

TypeBroad incumbent
Description

Parent company of SeaSpine since 2022; its spine solutions division now houses SeaSpine's implants, biologics, and 7D navigation, making it a directly comparable competitor externally as well.

TypeDirect peer
Description

Pure-play spine company with focus on surgeon-centric implants and procedurally integrated solutions; one of the closest direct comparables to SeaSpine's business model.

TypeDirect peer
Description

Operates a spine division (Aesculap) that competes with SeaSpine in spinal implants and is a relevant European/global comparable in the spine space.

TypeDirect peer
Description

Now merged with NuVasive, Globus is the largest pure-play spine company, competing directly with SeaSpine across spinal implants, biologics, and enabling technologies.

TypeDirect peer
Description

Spine and dental medical device company spun off from Zimmer Biomet; competes with SeaSpine in spinal fusion hardware and bone-healing biologics.

TypeBroad incumbent
Description

Market leader in spinal implants and enabling technologies (including Mazor robotics); directly competes with SeaSpine across fusion hardware, biologics, and navigation.

TypeEmerging player
Description

Emerging spine specialist competing with SeaSpine through focused implant platforms and a procedurally integrated go-to-market model targeting spine surgeons.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SeaSpine

Spinal Medical Devicesseaspine.com

SeaSpine Orthopedics Corporation develops and commercializes spinal implants, orthobiologics, and machine-vision surgical navigation systems for hospitals, surgical centers, and spine surgeons. Acquired by Orthofix Medical Inc. in 2022, it now operates within Orthofix's spine solutions division.

What SeaSpine does

SeaSpine Orthopedics Corporation is a Carlsbad, California-based medical technology company that designs, develops, and commercializes spinal implants and orthobiologics for use by healthcare professionals in spinal and cranial surgical procedures. The company's product portfolio is organized around two primary categories — Spinal Implants (hardware for spinal stabilization, fusion, and correction) and Orthobiologics (biologic products supporting bone healing and regeneration) — supplemented by surgical navigation technology acquired through the 2021 purchase of Toronto-based 7D Surgical. The 7D Surgical platform uses optical technologies and machine vision to enable image-guided surgical navigation, extending SeaSpine's clinical reach from implants into computer-vision-assisted procedures.

SeaSpine sells prescription-use medical devices through a direct enterprise field sales model targeting hospitals, surgical centers, and spine surgeons in the United States. Products are FDA-regulated prescription devices, with the company maintaining entries in the FDA's Global Unique Device Identification Database (GUDID) and providing electronic Instructions for Use (eIFU) to clinicians. Pricing is not publicly disclosed, consistent with enterprise medical device contracting.

In 2022, SeaSpine was acquired by Orthofix Medical Inc. (NASDAQ: ORFI) and now operates as part of Orthofix's spine solutions division. The combined Orthofix entity reported full-year 2025 net sales of $822.3 million, up 2.9% year-over-year. SeaSpine's products continue to be distributed under both the SeaSpine and 7D Surgical brand labels through the Orthofix commercial infrastructure, with the seaspine.com website now redirecting customers to Orthofix.com for the expanded portfolio.

SeaSpine firmographics

Firmographics
Name
SeaSpine
Legal name
SeaSpine Orthopedics Corporation
Website
https://seaspine.com
Company type
Private
Founded year
2015
Operating status
Acquired
Headcount range
1,001–5,000 employees
Short description
SeaSpine Orthopedics Corporation develops and commercializes spinal implants, orthobiologics, and machine-vision surgical navigation systems for hospitals, surgical centers, and spine surgeons. Acquired by Orthofix Medical Inc. in 2022, it now operates within Orthofix's spine solutions division.
Ownership category
akta.pro rank

SeaSpine industry classification

Industry
Product category
Spinal Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)
akta.pro secondary industries
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

  • Spinal implants
  • Orthobiologics products
  • Surgical navigation systems
  • Spinal fusion devices
  • Cranial surgery technology

Where SeaSpine is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SeaSpine business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Spinal Implants: Sale of spinal implant products including surgical hardware for spinal procedures
  2. Orthobiologics: Biologic products used in spinal and surgical applications including cancellous sponge medical products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

SeaSpine product offering

Product offering

Core offering

SeaSpine manufactures and sells prescription-use spinal implants and orthobiologics for spinal surgical procedures, including biologic products that support bone healing and surgical hardware for stabilization, fusion, and correction of spinal disorders. Following its 2021 acquisition of 7D Surgical, the company also offers optical and machine vision-based surgical navigation technology for spinal and cranial surgeries. Products are intended for use by healthcare professionals in hospital and surgical center settings.

Product overview

SeaSpine Orthopedics Corporation offers a portfolio of medical devices and products for spinal surgery, consisting of two main product categories: Orthobiologics (biologic products supporting bone healing and regeneration) and Spinal Implants (surgical devices for spinal stabilization and fusion). The company expanded its technological capabilities through the 2021 acquisition of 7D Surgical, adding optical and machine vision-based surgical navigation technology for spinal and cranial procedures. SeaSpine is now part of Orthofix, with its products integrated under the Orthofix brand portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • 7D Surgical: Optical technologies and machine vision system for surgical navigation acquired by SeaSpine in 2021

Products and services

  • Orthobiologics Biologic products used in orthopedic and spinal surgical procedures, designed to support bone healing and regeneration for healthcare professionals in hospital and surgical center settings.
  • Spinal Implants Surgical implants and devices used in spinal surgical procedures for stabilization, fusion, and correction of spinal disorders; intended for use by healthcare professionals.
  • 7D Surgical Navigation Optical technologies and machine vision-based surgical navigation systems for spinal and cranial surgeries, acquired by SeaSpine in 2021 to expand its technological capabilities for healthcare professionals.

Companies that use SeaSpine

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

SeaSpine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

SeaSpine partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

SeaSpine competitors and assessment

Company assessment

Direct peers

  • NuVasive: Spine-focused medtech specializing in minimally invasive and lateral spine surgery; competes with SeaSpine in spinal implants and procedural technologies.
  • Alphatec Holdings: Pure-play spine company with focus on surgeon-centric implants and procedurally integrated solutions; one of the closest direct comparables to SeaSpine's business model.
  • B. Braun: Operates a spine division (Aesculap) that competes with SeaSpine in spinal implants and is a relevant European/global comparable in the spine space.
  • Globus Medical: Now merged with NuVasive, Globus is the largest pure-play spine company, competing directly with SeaSpine across spinal implants, biologics, and enabling technologies.
  • ZimVie: Spine and dental medical device company spun off from Zimmer Biomet; competes with SeaSpine in spinal fusion hardware and bone-healing biologics.

Broad incumbents

  • DePuy Synthes (Johnson & Johnson MedTech): Broad orthopedics and spine franchise within J&J; competes with SeaSpine across spinal implants, biologics, and surgical enabling technologies.
  • Stryker: Operates a sizable Spine division alongside broader orthopedics; competes with SeaSpine in spinal implants and surgical navigation through its acquired enabling-technology assets.
  • Orthofix Medical: Parent company of SeaSpine since 2022; its spine solutions division now houses SeaSpine's implants, biologics, and 7D navigation, making it a directly comparable competitor externally as well.
  • Medtronic: Market leader in spinal implants and enabling technologies (including Mazor robotics); directly competes with SeaSpine across fusion hardware, biologics, and navigation.

Emerging players

  • ATEC Spine: Emerging spine specialist competing with SeaSpine through focused implant platforms and a procedurally integrated go-to-market model targeting spine surgeons.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

SeaSpine social profiles

Digital presence

SeaSpine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SeaSpine leadership team

Management profile

Number of profiles

Profiles8 records

SeaSpine subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

SeaSpine funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SeaSpine M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SeaSpine

What does SeaSpine do?

SeaSpine manufactures and sells prescription-use spinal implants and orthobiologics for spinal surgical procedures, including biologic products that support bone healing and surgical hardware for stabilization, fusion, and correction of spinal disorders. Following its 2021 acquisition of 7D Surgical, the company also offers optical and machine vision-based surgical navigation technology for spinal and cranial surgeries. Products are intended for use by healthcare professionals in hospital and surgical center settings.

Is SeaSpine a public or private company?

SeaSpine is a private company. It is classified as corporate owned and is currently acquired.

When was SeaSpine founded?

SeaSpine was founded in 2015. It employs 1,001 to 5,000 people.

Where is SeaSpine based?

SeaSpine is headquartered in Carlsbad, United States, in the North America region.

How does SeaSpine make money?

Two revenue lines are on record. Spinal Implants are the primary driver. The others are orthobiologics.

Who are SeaSpine's main competitors?

Direct peers on record are NuVasive, Alphatec Holdings, B. Braun, Globus Medical and ZimVie. Broad incumbents are DePuy Synthes (Johnson & Johnson MedTech), Stryker, Orthofix Medical and Medtronic. ATEC Spine is listed as an emerging player.

Does SeaSpine have an API?

No public API is recorded for SeaSpine.

What industry is SeaSpine in?

SeaSpine's product category is Spinal Medical Devices. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous), with a secondary code of HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTop Los Angeles Spine Surgeon Dr. Albert Wong Served as Faculty Leader at Advanced Spine Surgery Cadaver Training Courses for SeaSpine and GlobusDr. Albert Wong, neurosurgeon at DOCS Health, led two cadaver training courses in 2026: a SeaSpine-sponsored course for UC system residents and a Globus-sponsored course for practicing surgeons in San Diego. He taught minimally invasive endoscopic surgery, artificial disc replacement, and prone lateral transpsoas lumbar fusion, with the latter enabling 360-degree deformity correction.Venture Capital Access OnlineClarevia Ventures Welcomes Cheryl R. Blanchard, Ph.D., as Executive in ResidenceClarevia Ventures announced Cheryl R. Blanchard, former CEO of Anika Therapeutics, as Executive in Residence. She will advise on strategy, leadership, and commercialization. The role reflects Clarevia's commitment to providing operational counsel alongside capital.Business Wire BlogClarevia Ventures Welcomes Cheryl R. Blanchard, Ph.D., as Executive in ResidenceClarevia Ventures announced Cheryl R. Blanchard, former CEO of Anika Therapeutics, as Executive in Residence. She will advise on strategy, leadership, and commercialization, reflecting the firm's commitment to providing more than capital.PR NewswireSHAREHOLDER ALERT: Weiss Law Reminds OFIX, APEN, SAL, and BNFT Shareholders About Its Ongoing InvestigationsWeiss Law announced ongoing investigations into possible breaches of fiduciary duty by the boards of directors of four companies in connection with proposed mergers or acquisitions. The investigations cover Orthofix Medical Inc.'s proposed acquisition by SeaSpine Holdings Corporation, Apollo Endosurgery Inc.'s proposed acquisition by Boston Scientific Corporation, Salisbury Bancorp Inc.'s proposed merger with NBT Bancorp Inc., and Benefitfocus Inc.'s proposed acquisition by Voya Financial Inc. The law firm is urging shareholders of these companies to contact them to discuss their rights or interests regarding the transactions.GlobeNewswireOrthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post ClosingOrthofix and SeaSpine announced that John Bostjancic will serve as CFO of the combined company after their pending merger. Bostjancic, currently CFO and COO of SeaSpine, will lead integration, with Orthofix's CFO Doug Rice providing post-closing assistance. The merger is expected to close in the first quarter of 2023.PR NewswireSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of SeaSpine Holdings Corp. - SPNEMonteverde & Associates PC, a class action law firm, announced an investigation into SeaSpine Holdings Corp. regarding its proposed sale to Orthofix Medical Inc. Under the deal terms, SeaSpine shareholders will receive approximately 43.5% ownership in the combined company. The firm is encouraging SeaSpine shareholders to contact them for more information about protecting their investments.PR NewswireThinking about buying stock in Acumen Pharmaceuticals, Delta Air Lines, Blue Apron, United Airlines, or SeaSpine Holdings?InvestorsObserver issued PriceWatch Alerts for the stocks of Acumen Pharmaceuticals, Delta Air Lines, Blue Apron, United Airlines, and SeaSpine Holdings. The alerts utilize a proprietary scoring methodology that evaluates short-term technical, long-term technical, and fundamental factors to determine investment suitability. This serves as an informational update for investors regarding these specific equities.PR NewswireShareholder Alert: Ademi LLP investigates whether SeaSpine Holdings Corporation has obtained a Fair Price in its transaction with OrthofixAdemi LLP, a law firm, announced an investigation into SeaSpine Holdings Corporation regarding its transaction with Orthofix, alleging possible breaches of fiduciary duty and unfair pricing. The firm claims SeaSpine shareholders will receive only 0.4163 shares of Orthofix common stock per share owned, which may undervalue the company. The investigation also alleges that the transaction agreement unreasonably limits competing bids and that SeaSpine insiders will receive substantial change of control benefits.GlobeNewswireOrthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics CompanyOrthofix and SeaSpine announced an all-stock merger of equals, with SeaSpine shareholders receiving 0.4163 Orthofix shares per SeaSpine share. The combined company, expected to close in Q1 2023, will have revenues of about $693 million and is projected to be accretive to Orthofix's adjusted EBITDA by the second year.BioSpaceSeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit FacilityProvides for up to an additional $10 million of liquiditySeaSpine Holdings Corporation has amended its credit facility with Wells Fargo Bank, N.A., extending the maturity date to July 27, 2025, and securing an option to increase the borrowing limit by up to $10 million. This expansion provides additional liquidity intended to support new product launches and revenue growth for the medical technology company.